Nafithromycin: advancements in antibiotic therapy against community-acquired pneumonia-resistant pathogens
Nafithromycin (WCK 4873) is a novel lactone ketolide antibiotic developed to address the critical issue of multidrug-resistant bacteria, especially those causing community-acquired pneumonia (CAP). Given the increasing prevalence of antibiotic resistance, there is a pressing need for new antibiotic...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
PAGEPress Publications
2025-08-01
|
| Seri Bilgileri: | Monaldi Archives for Chest Disease |
| Konular: | |
| Online Erişim: | https://www.monaldi-archives.org/macd/article/view/3340 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|